Tag: Phase 1/2 trial

September 10, 2019

Rocket Pharmaceuticals Announces Data from Phase 1/2 Trial of RP-L102

Rocket Pharmaceuticals (NASDAQ:RCKT) has announced the publication of long-term data from its ongoing Phase 1/2 trial of RPL-102, the company’s...
March 26, 2019

Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib

Calithera Biosciences (NASDAQ:CALA) has announced the first patietn has been treated in its Phase 1/2 open-label clinical trial of the...
September 5, 2018

ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial

ProQR Therapeutics (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of...
September 4, 2018

Aeglea BioTherapeutics Announces Positive Clinical Update

Aeglea BioTherapeutics issued an update on Tuesday for its ongoing Phase 1/2 trial of pegzilarginase in patients with a rare...
April 21, 2017

Atara Will Join Forces with Merck for Clinical Trial

Atara Biotherapeutics announced a clinical trial collaboration agreement with Merck for an upcoming Phase 1/2 trial.